IRCT138806112406N1
Completed
Phase 3
Evaluation of therapeutic effect of oral N-Acetyl Cystein in comparison with placebo in patients diagnosed as subacute sinusitis, a double blind placebo controlled randomized clinical trial
Research managment center of Bushehr University of Medical Sciences0 sites45 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Research managment center of Bushehr University of Medical Sciences
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Presence of subacute sinusitis according to signs and symptoms 3 weeks to 3 months and signs of sinusitis in CT scan
- •Exclusion criteria: Presence of allergic rhinitis, asthma, pregnancy, diabetes mellitus, transplantation, CRF, chronic alcoholism, severe malnutrition, AIDS, Down syndrome, history of migraine, HTN, BPH, consumption of antidepressants, Methyl dopa, Propranolol, or Warfarin, history of kidney stone, or liver disease, more than 60 years old age, drivers, or pilots
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparing therapeutic efficacy of N-acetyl cysteine with the combination of N-acetyl cysteine and Cimetidine in acute acetaminophen toxicityAcute acetaminophen toxicity.Poisoning by drugs, medicaments and biological substancesT36, T37,IRCT2013102915204N1Vice chancellor for research, Mashhad University of Medical Sciences30
Recruiting
Phase 3
A comparative study on the effects of oral N-acetylcystein and Pregabalin on the blood level of oxidative stress biomarkers in patients with painful diabetic neuropathy.IRCT20180814040795N2Hamedan University of Medical Sciences140
Not yet recruiting
Phase 3
Efficacy of oral NAC and rectal indomethacin in prevention pancreatitis after ERCPIRCT20201222049798N1Ahvaz University of Medical Sciences280
Completed
Phase 3
Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N55Bagheiat-allah University of Medical Sciences250
Completed
Phase 3
Efficacy of N-acetylcysteine in patients with COVID-19covid-19.COVID-19U07.1IRCT20200623047897N1Iran University of Medical Sciences60